Table 1.
group | n | males | age | Disease duration (years) | BMI | HbA1c (%) | NDS |
---|---|---|---|---|---|---|---|
Diabetesa NDS (0–2) | 21 | 15 | 37.1 (16.5)b,c | 17.9 (15.1) | 26.4 (5.5) | 7.9 (1.3) | 0.381 (0.740) |
Diabetesa NDS (3–5) | 21 | 12 | 55.9 (11.0) | 33.5 (16.7) | 28.9 (3.8) | 8.6 (1.4) | 3.810 (0.928) |
Diabetesa NDS (6–8) | 19 | 11 | 59.0 (11.3) | 44.3 (11.0) | 28.4 (3.8) | 8.0 (1.1) | 6.895 (0.875) |
Diabetesa NDS (9–10) | 20 | 12 | 57.0 (14.6) | 28.1 (15.1) | 24.9 (7.2) | 7.8 (2.1) | 9.800 (0.410) |
Control | 48 | 25 | 46.2 (16.9) | NA | 26.4 (5.5) | 5.7 (0.3) | 0.425 (1.231) |
Sarcoidosis | 63 | 31 | 50.2 (10.0) | 11.1 (9.3) | 29.3 (5.5) | ND | ND |
Type 2 Diabetesd | 48 | 30 | 63.1 (7.0) | ND | 30.7 (4.4) | 7.2 (1.4) | ND |
aDiabetes group 1.
bSignificantly younger than the other groups.
cMean (standard deviation).
dDiabetes group 2.
NA: not applicable; ND: not determined.